Updated Jul 16, 2026
Lurker Nancy has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $302K.
Nancy Lurker is a corporate executive known for her role as a director at EyePoint Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. She has been involved in the pharmaceutical industry, focusing on innovative therapeutics for retinal diseases.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-23 | ALKS | Alkermes plc. | F — Tax withholding / forfeiture | 1.5K | $36.95 | $55K |
| 2026-05-23 | ALKS | Alkermes plc. | M — Option exercise | 6.1K | — | |
| 2026-05-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | A — Grant or award | 8.7K | $0.00 | |
| 2026-05-15 | COLL | COLLEGIUM PHARMACEUTICAL, INC | S — Open-market sale | 4.5K | $35.97 | $162K |
| 2026-04-13 | ALKS | Alkermes plc. | F — Tax withholding / forfeiture | 901 | $33.36 | $30K |
| 2026-04-13 | ALKS | Alkermes plc. | M — Option exercise | 3.8K | — | |
| 2025-12-05 | EYPT | EyePoint, Inc. | S — Open-market sale | 9.3K | $15.11 | $140K |
| 2025-07-10 | EYPT | EyePoint, Inc. | M — Option exercise | 11.1K | $0.00 | |
| 2025-05-15 | COLL | COLLEGIUM PHARMACEUTICAL, INC | A — Grant or award | 9.8K | $0.00 |
Nancy Lurker is a corporate executive known for her role as a director at EyePoint Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. She has been involved in the pharmaceutical industry, focusing on innovative therapeutics for retinal diseases.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($302K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lurker Nancy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.